ATG-Fresenius Trial Group. Standard graft-versus-host disease prophylaxis with or without anti-Tcell
globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label,
multicentre phase 3 trial

Bethge WA Finke J; Jorge Sierra Gil

ATG-Fresenius Trial Group. Standard graft-versus-host disease prophylaxis with or without anti-Tcell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

Department of Medicine

Research output: Contribution to journal › Article › Research

Original language	English
Pages (from-to)	855-864
Journal	Lancet Oncol
Volume	10
Issue number	9
Publication status	Published - 1 Jan 2009

Cite this

@article{d28d832b69714c81b0829bcfa4215963,

title = "ATG-Fresenius Trial Group. Standard graft-versus-host disease prophylaxis with or without anti-Tcell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial",

author = "{Finke J}, {Bethge WA} and {Sierra Gil}, Jorge",

year = "2009",

month = jan,

day = "1",

language = "English",

volume = "10",

pages = "855--864",

number = "9",

}

ATG-Fresenius Trial Group. Standard graft-versus-host disease prophylaxis with or without anti-Tcell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. / Finke J, Bethge WA; Sierra Gil, Jorge.

In: Lancet Oncol, Vol. 10, No. 9, 01.01.2009, p. 855-864.

Research output: Contribution to journal › Article › Research

TY - JOUR

T1 - ATG-Fresenius Trial Group. Standard graft-versus-host disease prophylaxis with or without anti-Tcell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

AU - Finke J, Bethge WA

AU - Sierra Gil, Jorge

PY - 2009/1/1

Y1 - 2009/1/1

M3 - Article

VL - 10

SP - 855

EP - 864

IS - 9

ER -